Nexalin Technology Inc Warrant
NXLIW
NXLIW was delisted on the 19th of September, 2025.
7 hedge funds and large institutions have $11.7K invested in Nexalin Technology Inc Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
0.19% less ownership
Funds ownership: 9.96% → 9.77% (-0.19%)
51% less capital invested
Capital invested by funds: $23.8K → $11.7K (-$12K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$9 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2 |
| 3 |
CS
Clear Street
New York
|
+$1 |
Top Sellers
NXLIW Hedge Fund Activity: Q4 2023 in Review
7 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology Inc Warrant (NXLIW) for Q4 2023, worth a combined $11.7K — down 51% from $23.8K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NXLIW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $9.
- 7 institutional investors held Nexalin Technology Inc Warrant (NXLIW) as of Q4 2023, up from 6 in Q3 2023.
- Funds reported $11.7K of Nexalin Technology Inc Warrant stock for Q4 2023, down 51% quarter-over-quarter.
- 1 fund opened new Nexalin Technology Inc Warrant positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest Nexalin Technology Inc Warrant buyer in Q4 2023 was Citadel Advisors, an estimated $9 added.
Based on aggregated 13F filings for Q4 2023.